NIO
NIO Inc.
NIO has the edge over RGS overall, supported by lower modeled downside and stronger modeled upside.
RGS
Regis Corporation
RGS trails on the overall score without a compensating advantage in the available component scores.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
RGS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Under pressure |
RGS's profitability and cash flow are currently stable, but its revenue and balance sheet are under pressure.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
RGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.5x | $1.05 | -96% |
| Fair | 0.6x | $1.27 | -95% |
| Expensive | 0.7x | $1.39 | -94% |
| Current | 11x | $23.55 | — |
Historical ranges are pointers, not guarantees.
RGS's PE is in its expensive range at 11x.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
RGS Forward outlook
There aren't enough analyst estimates for RGS to show an outlook.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
RGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.10 | -96% |
| Q2 2026 | $2.41 | -95% |
| Q1 2026 | $44.58 | +9.4% |
| Q4 2025 | $44.40 | +12% |
| Q3 2025 | $46.95 | +26% |
| Q2 2025 | $46.10 | +20% |
| Q1 2025 | $40.74 | +$42.71 |
| Q4 2024 | $39.66 | +$41.43 |
RGS has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over RGS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
RGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.3M | -7.8% |
| Q2 2026 | $56M | -7.3% |
| Q1 2026 | $52.4M | -8% |
| Q4 2025 | $57.1M | +22% |
| Q3 2025 | $59M | +28% |
| Q2 2025 | $60.4M | +22% |
| Q1 2025 | $57M | +16% |
| Q4 2024 | $46.7M | -8.5% |
RGS's revenue fell from its 2019 peak and has held roughly level since: $54M last quarter, down 7.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.8% | -0.3 points |
| Q2 2026 | 12% | -0.3 points |
| Q1 2026 | 11% | +2.1 points |
| Q4 2025 | 11% | -0.9 points |
| Q3 2025 | 10% | +5.4 points |
| Q2 2025 | 12% | +2.8 points |
| Q1 2025 | 8.8% | +0.5 points |
| Q4 2024 | 12% | +2.4 points |
RGS has the edge over NIO on profitability, with a higher operating margin.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
RGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.1M | +11% |
| Q2 2026 | $3.6M | -42% |
| Q1 2026 | $4.8M | -19% |
| Q4 2025 | $891K | -48% |
| Q3 2025 | $1.9M | +$3.2M |
| Q2 2025 | $6.2M | +23% |
| Q1 2025 | $5.9M | +$6.2M |
| Q4 2024 | $1.7M | +$5.9M |
RGS has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.1x | High |
| Q1 2025 | 4.8x | High |
| Q4 2024 | 5.2x | High |
RGS's net debt is about 3.2 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
RGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 35.1 | Neutral |
RGS's weekly RSI is 36 (neutral) and its Stochastic is 35 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
RGS PE vs Consumer Cyclical Sector
| Metric | RGS | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 38% below |
| PE % | 92 | 47 | 45 pts above |
RGS is trading at 11x earnings, a 38% discount to the Consumer Cyclical sector's median of 18x.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
RGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.8 | 15% below |
| 20 week MA | $27.7 | 15% below |
| 50 week MA | $26.5 | 11% below |
| 100 week MA | $24.8 | 5% below |
| 200 week MA | $21.2 | 11% above |
RGS has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
RGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $359.0 | $189.6 | -47% |
| 2021 | $189.6 | $33.8 | -82% |
| 2022 | $33.8 | $24.2 | -28% |
| 2023 | $24.2 | $9.45 | -61% |
| 2024 | $9.45 | $25.5 | +170% |
| 2025 | $25.5 | $27.4 | +7.4% |
| 2026 YTD | $27.4 | $23.6 | -14% |
RGS has the edge over NIO on returns for 2026, with the stronger performance.